FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation

Journal of Urology

Volumn 162, Issue 2, 1999, Pages 595-599

  Ropiquet, Frederic ^a   Giri, Dipak ^a   Lamb, Dolores J ^a   Ittmann, Michael ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell proliferation; Fibroblast growth factor; Prostatic hyperplasia

Indexed keywords

ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE ACTIVITY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOGENESIS; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; STROMA CELL;

EID: 0032828817     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)68632-6     Document Type: Article

References (17)

1. Guess, H.: The epidemiology and natural history of benign prostatic hyperplasia. Handbook on Benign Prostatic Hyperplasia. Edited by Chisholm, G. Whitehouse Station N. J., Merck and Co., Inc, Chapter 1, pp. 1-18, 1994.
2. Culig, Z., Hobisch, A., Cronauer, M., Radmayr, C., Hittmair, A., Zhang, J., Thurnher, M., Bartsch, G. and Klocker, H.: Regulation of prostatic growth and function by peptide growth factors. Prostate, 28: 392, 1996.
3. Johnson, D. and Williams, L.: Structural and functional diversity in the FGF receptor multigene family. Adv. Cancer Res., 60: 1, 1993.
4. Ornitz, D., Xu, J., Colvin, J., McEwen, D., MacArthur, C., Coulier, F., Gao, G. and Goldfarb, M.: Receptor specificity of the fibroblast growth factor family. J. Biol. Chem., 271: 15292, 1996.
5. Story, M., Hopp, K., Molter, M. and Meier, D.: Characteristics of FGF-receptors expressed by stromal and epithelial cells cultured from normal and hyperplastic prostates. Growth Factors, 10.: 269, 1994.
6. Sherwood, E., Fong, C., Lee, C. and Kozlowski, J.: Basic fibroblast growth factor: A potential mediator of stromal growth in the human prostate. Endocrinology, 130: 2955, 1992.
7. Ittmann, M. and Mansukhani, A.: Expression of fibroblast growth factors (FGFs) and FGF receptors in human prostate. J. Urol., 157: 351, 1997.
8. Wheeler, T. and Lebovitz, R.: Fresh tissue harvest for research from prostatectomy specimens. Prostate, 25: 274, 1994.
9. Bradford, M.: A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72: 248,1976.
10. Shapiro, E., Hartanto, V. and Lepor, H.: Quantifying the smooth muscle content of the prostate using double immunenzymatic staining and color assisted image analysis. J. Urol., 147: 1167, 1992.
11. Shapiro, E., Becich, M., Hartanto, V. and Lepor, H.: The relative proportion of stromal and epithelial hyperplasia is related to the development of symptomatic BPH. J. Urol., 147: 1293, 1992.
12. Siegel, Y., Zaidel, L. and Hanmel, I.: Morphometric evaluation of benign prostatic hyperplasia. Eur. Urol., 18: 71, 1990.
13. Begun, F., Story, M., Hopp, K., Shapiro, E. and Lawson, R.: Regional concentration of basic fibroblast growth factor in normal and benign hyperplastic prostates. J. Urol., 153: 839, 1995.
14. Mori, H., Maki, M., Oishi, K., Jaye, M., Igarash, K., Yoshida, O. and Hatanaka, M.: Increased expression of genes for basic fibroblast growth factor and transforming growth factor type B2 in human benign prostatic hyperplasia. Prostate, 16: 71, 1990.
15. Colton, T.: Statistics in Medicine, first edition, Boston: Little, Brown and Co., pp 210-211.
16. Kyprianou, N., Tu, H. and Jacobs, S.: Apoptotic versus proliferative activities in human benign prostatic hyperplasia. Hum. Pathol., 27: 668, 1996.
17. Basilico, C. and Moscatelli, D.: The FGF family of growth factors and oncogenes. Adv. Canc. Res., 59: 115, 1992.